MagLira 5mg Semaglutide | Pre-Filled Pen

Lira Pharma MagLira 5mg is a multi-dose pre-filled injection pen containing semaglutide, a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist. Semaglutide acts on receptors involved in appetite regulation, glucose control and digestion.

Semaglutide is widely studied and clinically used for type 2 diabetes and chronic weight management, depending on the specific approved formulation and indication.

What Lira Pharma MagLira 5mg Is Used For

Semaglutide is associated with:

Supporting weight loss and long-term weight management

Helping to reduce appetite and calorie intake

Increasing feelings of fullness and satiety

Supporting improved blood-glucose control

Helping reduce food cravings and overall food intake

Supporting improvements in certain metabolic health markers

Its effects on appetite and calorie intake contribute significantly to the reductions in body weight observed with semaglutide treatment.

How Lira Pharma MagLira 5mg Works

Semaglutide mimics the activity of naturally occurring GLP-1, a hormone involved in appetite and glucose regulation.

It works by:

Activating GLP-1 receptors

Increasing glucose-dependent insulin secretion

Reducing glucagon secretion when blood glucose is elevated

Helping regulate appetite and calorie intake

Slowing gastric emptying, which can contribute to prolonged feelings of fullness

These combined effects can support both blood-glucose regulation and body-weight reduction.

How to Use Lira Pharma MagLira 5mg

MagLira is supplied as a pre-filled multi-dose pen, eliminating the need to reconstitute a separate peptide vial.

Semaglutide injection is generally administered once weekly, preferably on the same day each week. The exact dose and escalation schedule should be determined by a qualified healthcare professional rather than solely from click counts, as pen concentrations and delivery systems can differ between products.

Administration Route: Subcutaneous injection. Common injection areas include the abdomen, thigh or upper arm.

Dosage Information

Total labelled content per pen: 5mg Semaglutide

The product packaging shows a click-based multi-dose system. However, dosing should be based on the milligram dose and verified concentration of the specific pen, rather than assuming click counts are interchangeable with other semaglutide products.

Semaglutide treatment commonly uses gradual dose escalation to improve gastrointestinal tolerability. The appropriate dose should be established according to individual requirements and professional medical guidance.

Never share a pre-filled injection pen with another person, even when using a new needle.

Possible Side Effects

Semaglutide is commonly associated with gastrointestinal side effects, particularly when treatment begins or the dose is increased.

Common

Nausea

Vomiting

Diarrhoea

Constipation

Abdominal discomfort or pain